Frontline Aspacytarabine with Venetoclax for Older/Unfit Patients with Acute Myeloid Leukemia: Preliminary Results of a Phase 1 Study

被引：0

作者：

Altman, Jessica K. ^{[1
]}

Abaza, Yasmin ^{[2
]}

Keng, Michael ^{[3
]}

Maiti, Abhishek ^{[4
]}

Koprivnikar, Jamie ^{[5
]}

Tessler, Shoshi ^{[6
]}

Blumberg, Chen ^{[6
]}

Flaishon, Liat ^{[6
]}

Ben Yakar, Ruth ^{[6
]}

机构：

[1] Northwestern Univ, Chicago, IL 60611 USA

[2] Northwestern Med, Chicago, IL USA

[3] Univ Virginia Hlth Syst, Div Hematol Oncol, Charlottesville, VA USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[5] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[6] BioSight Ltd, Tel Aviv, Israel

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-185694

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study
Garcia-Manero, Guillermo
Abaza, Yasmin
Takahashi, Koichi
Medeiros, Bruno C.
Arellano, Martha
Khaled, Samer K.
Patnaik, Mrinal
Odenike, Olatoyosi
Sayar, Hamid
Tummala, Mohan
Patel, Prapti
Maness-Harris, Lori
Stuart, Robert
Traer, Elie
Karamlou, Kasra
Yacoub, Abdulraheem
Ghalie, Richard
Giorgino, Ruben
Atallah, Ehab
BLOOD ADVANCES, 2019, 3 (04) : 508 - 518
[42] Phase II Study of CPX-351 Plus Venetoclax in Patients with Acute Myeloid Leukemia (AML)
Kadia, Tapan M.
Borthakur, Gautam
Takahashi, Koichi
DiNardo, Courtney D.
Daver, Naval
Pemmaraju, Naveen
Jabbour, Elias
Jain, Nitin
Short, Nicholas J.
Qiao, Wei
Adewale, Lade
Rausch, Caitlin R.
Pierce, Sherry A.
Alvarado, Yesid
Alousi, Amin M.
Popat, Uday R.
Khouri, Issa F.
Garcia-Manero, Guillermo
Konopleva, Marina
Cortes, Jorge E.
Ravandi, Farhad
Kantarjian, Hagop M.
BLOOD, 2020, 136
[43] A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemia
Liu, Yuchen
Bollino, Dominique R.
Bah, Osman M.
Strovel, Erin T.
Le, Tien, V
Zarrabi, Jinoos
Philip, Sunita
Lapidus, Rena G.
Baer, Maria R.
Niyongere, Sandrine
Duong, Vu H.
Dougherty, Christine C.
Beumer, Jan H.
Caprinolo, Katherine D.
Kamangar, Farin
Emadi, Ashkan
BLOOD, 2025, 145 (05) : 486 - 496
[44] A Randomized Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) Who Are Unfit for Intensive Chemotherapy
Short, Nicholas J.
Sedarati, Farhad
Zhao, Dan
Tsukurov, Olga
Friedlander, Sharon
Faller, Douglas V.
BLOOD, 2020, 136
[45] Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study
Al-Ali, Haifa K.
Jaekel, Nadja
Junghanss, Christian
Maschmeyer, Georg
Krahl, Rainer
Cross, Michael
Hoppe, Gisa
Niederwieser, Dietger
LEUKEMIA & LYMPHOMA, 2012, 53 (01) : 110 - 117
[46] More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabine
Aldoss, Ibrahim
Marcucci, Guido
CHINESE CLINICAL ONCOLOGY, 2019, 8
[47] A Phase I/II Study of Combination of ASTX727, Gilteritinib and Venetoclax in Patients with Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia (AML) and Frontline FLT3 Mutated AML Patients Unfit for Chemotherapy
Ong, Faustine
Short, Nicholas
Daver, Naval
Kadia, Tapan M.
DiNardo, Courtney D.
Yilmaz, Musa
Alvarado, Yesid
Vaughan, Kenneth
Pierce, Sherry A.
Kantarjian, Hagop
Garcia-Manero, Guillermo
Ravandi, Farhad
BLOOD, 2022, 140 : 9029 - 9031
[48] UPDATED SAFETY AND EFFICACY RESULTS OF PHASE 1/2 STUDY OF VENETOCLAX PLUS LOW-DOSE CYTARABINE IN TREATMENT-NAIVE ACUTE MYELOID LEUKEMIA PATIENTS AGED ≥65 YEARS AND UNFIT FOR STANDARD INDUCTION THERAPY
Wei, A. H.
Strickland, S. A.
Roboz, G. J.
Hou, J. -Z.
Fiedler, W.
Lin, T. L.
Martinelli, G.
Walter, R. B.
Enjeti, A.
Fakouhi, K. M.
Darden, D. E.
Dunbar, M.
Xu, T.
Mabry, M.
Hayslip, J.
HAEMATOLOGICA, 2017, 102 : 176 - 176
[49] Venetoclax in Combination with Intermediate Doses of Cytarabine in Consolidation Phase for Acute Myeloid Leukemia Patients in First Complete Remission; Results of the Part 1 of the Phase 1/2 Multicentric Covenidac Study
Gastaud, Lauris
Peterlin, Pierre
Hunault, Mathilde
Raffoux, Emmanuel
Bertoli, Sarah
Carre, Martin
Pautas, Cecile
Chantepie, Sylvain
Lambert, Juliette
Duployez, Nicolas
Celli-Lebras, Karine
Mineur, Ariane
Gardin, Claude
Vey, Norbert
Pigneux, Arnaud
Delabesse, Eric
Preudhomme, Claude
Plesa, Adriana
Vergez, Francois
Hamel, Jean-Francois
Dombret, Herve
Recher, Christian
BLOOD, 2023, 142
[50] Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
Budziszewska, Bozena Katarzyna
Salomon-Perzynski, Aleksander
Pruszczyk, Katarzyna
Barankiewicz, Joanna
Pluta, Agnieszka
Helbig, Grzegorz
Janowska, Anna
Kuydowicz, Marta
Bolkun, Lukasz
Piszcz, Jaroslaw
Patkowska, Elzbieta
Watek, Marzena
Malecki, Piotr
Kosciolek-Zgodka, Sylwia
Cichocka, Edyta
Charlinski, Grzegorz
Irga-Staniukiewicz, Anna
Zaucha, Jan Maciej
Piekarska, Agnieszka
Gromek, Tomasz
Hus, Marek
Wojcik, Karol
Razny, Malgorzata
Sedzimirska, Mariola
Pula, Bartosz
Giebel, Sebastian
Grosicki, Sebastian
Wierzbowska, Agnieszka
Lech-Maranda, Ewa
CANCERS, 2021, 13 (16)

← 1 2 3 4 5 →